Follow the 웰바이오텍 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Retail sector, 웰바이오텍 has recorded 52 insider filings. The latest transaction was disclosed on 27 January 2026 (Purchase). Among the most active insiders: 메타프리즈. All data is accessible without an account.
52
Insider Decl.
n/a
Thresholds
n/a
30 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.